![](/img/cover-not-exists.png)
50 Pharmacokinetic comparison of inhaled tobramycin (TOBI®) via PARI eFlow® rapid or PARI LC Plus™ nebulizers in cystic fibrosis patients
D. Hubert, S. Leroy, S. Dominique, J. KovarikVolume:
6
Year:
2007
Language:
english
DOI:
10.1016/s1569-1993(07)60043-5
File:
PDF, 64 KB
english, 2007